Neuroendocrine Carcinoma of the Skin

Also known as: Merkel Cell Carcinoma (Disorder) / Merkel-cell Carcinoma / Merkel Cell Carcinoma (MCC) / Carcinoma, Merkel Cell / Merkel Cell Carcinoma / Merkel cell carcinoma of unspecified site / Merkel cell carcinoma (morphologic abnormality) / Apudoma of skin (disorder)

DrugDrug NameDrug Description
DB00958CarboplatinA alkylating agent used to treat advanced ovarian cancer.
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin1Recruiting1
DB11595Atezolizumab1Recruiting1
DB01101Capecitabine1Withdrawn1
DB14707Cemiplimab1Recruiting1
DB15770Cosibelimab1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Recruiting1
DB00724Imiquimod1Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB12089Lorvotuzumab mertansine1Completed1
DB00683Midazolam1Active Not Recruiting1
DB00220Nelfinavir1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09035Nivolumab1Recruiting1
DB09330Osimertinib1Recruiting1
DB09037Pembrolizumab1Recruiting4
DB00853Temozolomide1Withdrawn1
DB07232Veliparib1Withdrawn1
DB11595Atezolizumab1 / 2Recruiting1
DB11945Avelumab1 / 2Withdrawn1
DB15140Bempegaldesleukin1 / 2Active Not Recruiting1
DB00112Bevacizumab1 / 2Withdrawn1
DB01101Capecitabine1 / 2Withdrawn1
DB00515Cisplatin1 / 2Withdrawn1
DB00531Cyclophosphamide1 / 2Withdrawn1
DB11714Durvalumab1 / 2Active Not Recruiting1
DB16395Efineptakin alfa1 / 2Recruiting1
DB00544Fluorouracil1 / 2Withdrawn1
DB16479Inbakicept1 / 2Withdrawn1
DB00650Leucovorin1 / 2Withdrawn1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB09539Omega-3-acid ethyl esters1 / 2Withdrawn1
DB01229Paclitaxel1 / 2Withdrawn1
DB09037Pembrolizumab1 / 2Recruiting2
DB11836Sapanisertib1 / 2Completed1
DB11771Tremelimumab1 / 2Active Not Recruiting1
DB11702Antineoplaston A102Withdrawn1
DB11595Atezolizumab2Active Not Recruiting1
DB11945Avelumab2Active Not Recruiting2
DB11945Avelumab2Not Yet Recruiting1
DB11945Avelumab2Recruiting4
DB05153Cabozantinib2Active Not Recruiting1
DB08875Cabozantinib2Active Not Recruiting1
DB00958Carboplatin2Active Not Recruiting1
DB00531Cyclophosphamide2Completed1
DB00531Cyclophosphamide2Recruiting1
DB11714Durvalumab2Active Not Recruiting1
DB00773Etoposide2Active Not Recruiting1
DB01073Fludarabine2Recruiting1
DB00544Fluorouracil2Completed1
DB16479Inbakicept2Active Not Recruiting1
DB16479Inbakicept2Recruiting1
DB06186Ipilimumab2Recruiting1
DB06186Ipilimumab2Withdrawn1
DB00762Irinotecan2Completed1
DB06791Lanreotide2Completed1
DB09078Lenvatinib2Recruiting1
DB00563Methotrexate2Completed1
DB15299Navtemadlin2Recruiting1
DB09035Nivolumab2Active Not Recruiting2
DB09035Nivolumab2Recruiting2
DB01229Paclitaxel2Terminated1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB09037Pembrolizumab2Terminated1
DB13896Talimogene laherparepvec2Active Not Recruiting1
DB13896Talimogene laherparepvec2Recruiting1
DB09037Pembrolizumab3Active Not Recruiting1